45,229 Shares in Masimo Co. (MASI) Acquired by Nicholas Investment Partners LP

Nicholas Investment Partners LP acquired a new stake in shares of Masimo Co. (NASDAQ:MASI) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 45,229 shares of the medical equipment provider’s stock, valued at approximately $3,915,000. Nicholas Investment Partners LP owned 0.09% of Masimo as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also bought and sold shares of the stock. Convergence Investment Partners LLC lifted its stake in Masimo by 9.9% during the third quarter. Convergence Investment Partners LLC now owns 50,356 shares of the medical equipment provider’s stock worth $4,359,000 after purchasing an additional 4,532 shares during the last quarter. OxFORD Asset Management LLP lifted its stake in Masimo by 193.9% during the third quarter. OxFORD Asset Management LLP now owns 17,956 shares of the medical equipment provider’s stock worth $1,546,000 after purchasing an additional 11,847 shares during the last quarter. WINTON GROUP Ltd bought a new stake in Masimo during the third quarter worth about $4,172,000. Schroder Investment Management Group lifted its stake in Masimo by 16.7% during the third quarter. Schroder Investment Management Group now owns 338,115 shares of the medical equipment provider’s stock worth $28,709,000 after purchasing an additional 48,300 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its stake in Masimo by 6.0% during the third quarter. JPMorgan Chase & Co. now owns 851,234 shares of the medical equipment provider’s stock worth $72,278,000 after purchasing an additional 48,536 shares during the last quarter. 83.74% of the stock is owned by institutional investors.

In related news, EVP Yongsam Lee sold 18,198 shares of the business’s stock in a transaction dated Monday, December 4th. The stock was sold at an average price of $88.85, for a total transaction of $1,616,892.30. Following the transaction, the executive vice president now owns 70,800 shares in the company, valued at approximately $6,290,580. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Steven Barker sold 10,000 shares of the business’s stock in a transaction dated Wednesday, November 1st. The shares were sold at an average price of $90.00, for a total value of $900,000.00. Following the transaction, the director now owns 73,249 shares in the company, valued at approximately $6,592,410. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 53,074 shares of company stock worth $4,737,245. 13.10% of the stock is owned by company insiders.

MASI has been the topic of several analyst reports. BidaskClub downgraded Masimo from a “hold” rating to a “sell” rating in a report on Wednesday, August 9th. BTIG Research upgraded Masimo from a “neutral” rating to a “buy” rating and set a $100.00 price objective on the stock in a report on Monday, August 14th. Zacks Investment Research downgraded Masimo from a “buy” rating to a “hold” rating in a report on Tuesday, October 3rd. Finally, Stifel Nicolaus reiterated a “buy” rating and issued a $108.00 price objective on shares of Masimo in a report on Friday, November 3rd. One analyst has rated the stock with a sell rating, three have given a hold rating and five have issued a buy rating to the stock. Masimo has a consensus rating of “Hold” and an average target price of $97.17.

Masimo Co. (NASDAQ:MASI) opened at $88.47 on Tuesday. The company has a market capitalization of $4,592.53, a PE ratio of 34.05, a PEG ratio of 2.99 and a beta of 0.72. Masimo Co. has a twelve month low of $60.31 and a twelve month high of $104.71.

Masimo (NASDAQ:MASI) last announced its quarterly earnings results on Tuesday, October 31st. The medical equipment provider reported $0.70 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.53 by $0.17. Masimo had a return on equity of 22.17% and a net margin of 45.83%. The company had revenue of $193.69 million for the quarter, compared to the consensus estimate of $189.01 million. During the same quarter in the previous year, the business earned $0.52 EPS. Masimo’s revenue was up 15.6% compared to the same quarter last year. analysts expect that Masimo Co. will post 2.95 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “45,229 Shares in Masimo Co. (MASI) Acquired by Nicholas Investment Partners LP” was first reported by Community Financial News and is the sole property of of Community Financial News. If you are viewing this news story on another domain, it was illegally copied and reposted in violation of U.S. and international copyright law. The legal version of this news story can be accessed at https://www.com-unik.info/2017/12/05/45229-shares-in-masimo-co-masi-acquired-by-nicholas-investment-partners-lp.html.

Masimo Company Profile

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASI).

Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

What are top analysts saying about Masimo Co.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Masimo Co. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit